232 related articles for article (PubMed ID: 37506213)
21. Posttranscriptional RNA Pseudouridylation.
De Zoysa MD; Yu YT
Enzymes; 2017; 41():151-167. PubMed ID: 28601221
[TBL] [Abstract][Full Text] [Related]
22. Domain specific mutations in dyskerin disrupt 3' end processing of scaRNA13.
Nagpal N; Tai AK; Nandakumar J; Agarwal S
Nucleic Acids Res; 2022 Sep; 50(16):9413-9425. PubMed ID: 36018809
[TBL] [Abstract][Full Text] [Related]
23. Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects.
Brault ME; Lauzon C; Autexier C
Hum Mol Genet; 2013 Sep; 22(17):3498-507. PubMed ID: 23660516
[TBL] [Abstract][Full Text] [Related]
24. Gene structure and expression of the mouse dyskeratosis congenita gene, dkc1.
Heiss NS; Bächner D; Salowsky R; Kolb A; Kioschis P; Poustka A
Genomics; 2000 Jul; 67(2):153-63. PubMed ID: 10903840
[TBL] [Abstract][Full Text] [Related]
25. Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis.
Bellodi C; Krasnykh O; Haynes N; Theodoropoulou M; Peng G; Montanaro L; Ruggero D
Cancer Res; 2010 Jul; 70(14):6026-35. PubMed ID: 20587522
[TBL] [Abstract][Full Text] [Related]
26. DKC1 Overexpression Induces a More Aggressive Cellular Behavior and Increases Intrinsic Ribosomal Activity in Immortalized Mammary Gland Cells.
Guerrieri AN; Zacchini F; Onofrillo C; Di Viggiano S; Penzo M; Ansuini A; Gandin I; Nobe Y; Taoka M; Isobe T; Treré D; Montanaro L
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33255756
[TBL] [Abstract][Full Text] [Related]
27. Dyskerin depletion increases VEGF mRNA internal ribosome entry site-mediated translation.
Rocchi L; Pacilli A; Sethi R; Penzo M; Schneider RJ; Treré D; Brigotti M; Montanaro L
Nucleic Acids Res; 2013 Sep; 41(17):8308-18. PubMed ID: 23821664
[TBL] [Abstract][Full Text] [Related]
28. GSE4, a Small Dyskerin- and GSE24.2-Related Peptide, Induces Telomerase Activity, Cell Proliferation and Reduces DNA Damage, Oxidative Stress and Cell Senescence in Dyskerin Mutant Cells.
Iarriccio L; Manguán-García C; Pintado-Berninches L; Mancheño JM; Molina A; Perona R; Sastre L
PLoS One; 2015; 10(11):e0142980. PubMed ID: 26571381
[TBL] [Abstract][Full Text] [Related]
29. Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita.
Parry EM; Alder JK; Lee SS; Phillips JA; Loyd JE; Duggal P; Armanios M
J Med Genet; 2011 May; 48(5):327-33. PubMed ID: 21415081
[TBL] [Abstract][Full Text] [Related]
30. Dyskerin ablation in mouse liver inhibits rRNA processing and cell division.
Ge J; Rudnick DA; He J; Crimmins DL; Ladenson JH; Bessler M; Mason PJ
Mol Cell Biol; 2010 Jan; 30(2):413-22. PubMed ID: 19917719
[TBL] [Abstract][Full Text] [Related]
31. DKC1 overexpression associated with prostate cancer progression.
Sieron P; Hader C; Hatina J; Engers R; Wlazlinski A; Müller M; Schulz WA
Br J Cancer; 2009 Oct; 101(8):1410-6. PubMed ID: 19755982
[TBL] [Abstract][Full Text] [Related]
32. Defects in mTR stability and telomerase activity produced by the Dkc1 A353V mutation in dyskeratosis congenita are rescued by a peptide from the dyskerin TruB domain.
Machado-Pinilla R; Carrillo J; Manguan-Garcia C; Sastre L; Mentzer A; Gu BW; Mason PJ; Perona R
Clin Transl Oncol; 2012 Oct; 14(10):755-63. PubMed ID: 22855157
[TBL] [Abstract][Full Text] [Related]
33. Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis.
Knight SW; Vulliamy TJ; Morgan B; Devriendt K; Mason PJ; Dokal I
Hum Genet; 2001 Apr; 108(4):299-303. PubMed ID: 11379875
[TBL] [Abstract][Full Text] [Related]
34. p53 pathway activation by telomere attrition in X-DC primary fibroblasts occurs in the absence of ribosome biogenesis failure and as a consequence of DNA damage.
Carrillo J; González A; Manguán-García C; Pintado-Berninches L; Perona R
Clin Transl Oncol; 2014 Jun; 16(6):529-38. PubMed ID: 24065372
[TBL] [Abstract][Full Text] [Related]
35. Oxidatively Modified Protein-Disulfide Isomerase-Associated 3 Promotes Dyskerin Pseudouridine Synthase 1-Mediated Malignancy and Survival of Hepatocellular Carcinoma Cells.
Ko E; Kim JS; Ju S; Seo HW; Chang Y; Kang JA; Park SG; Jung G
Hepatology; 2018 Nov; 68(5):1851-1864. PubMed ID: 29672884
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of human dyskerin as a new approach to target ribosome biogenesis.
Rocchi L; Barbosa AJ; Onofrillo C; Del Rio A; Montanaro L
PLoS One; 2014; 9(7):e101971. PubMed ID: 25010840
[TBL] [Abstract][Full Text] [Related]
37. Dyskeratosis congenita: a disorder of defective telomere maintenance?
Walne AJ; Marrone A; Dokal I
Int J Hematol; 2005 Oct; 82(3):184-9. PubMed ID: 16207588
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.
Shukla S; Schmidt JC; Goldfarb KC; Cech TR; Parker R
Nat Struct Mol Biol; 2016 Apr; 23(4):286-92. PubMed ID: 26950371
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.
Vulliamy T; Beswick R; Kirwan M; Marrone A; Digweed M; Walne A; Dokal I
Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8073-8. PubMed ID: 18523010
[TBL] [Abstract][Full Text] [Related]
40. Relationship between dyskerin expression and telomerase activity in human breast cancer.
Montanaro L; Calienni M; Ceccarelli C; Santini D; Taffurelli M; Pileri S; Treré D; Derenzini M
Cell Oncol; 2008; 30(6):483-90. PubMed ID: 18936525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
